Placebo controlled investigation on action of acarbose on the sub-clinical inflammation and immune response in early type 2 diabetes and atherosclerosis risk
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acarbose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms AIDA
- 11 Apr 2008 Biomarkers information updated
- 20 Nov 2007 New trial record.